The Scientist

» drug development, ecology and microbiology

Most Recent

image: Gut Microbes Linked to Neurodegenerative Disease

Gut Microbes Linked to Neurodegenerative Disease

By | December 1, 2016

Bacteria in the intestine influence motor dysfunction and neuroinflammation in a mouse model of Parkinson’s disease.

3 Comments

image: Biomedical Research Bill Approved in House

Biomedical Research Bill Approved in House

By | December 1, 2016

The 21st Century Cures Act could provide funds to federal research agencies for the decade and accelerate the drug approval process.

1 Comment

image: Elephant Footprints Create Habitat for Tiny Aquatic Creatures

Elephant Footprints Create Habitat for Tiny Aquatic Creatures

By | December 1, 2016

Researchers discover diverse communities of invertebrates inhabiting the water-filled tracks of elephants in Uganda.

0 Comments

image: Oligonucleotide Therapeutics Near Approval

Oligonucleotide Therapeutics Near Approval

By | December 1, 2016

Successful late-stage clinical trials could mark the maturation of a new drug development platform, but the path to commercialization is not without hurdles.

0 Comments

Different assays lead to opposing conclusions on bacterial spores’ requirements during germination.

0 Comments

A new literature review finds that even if babies born via Cesarean section have long-term health risks, as a number of past studies purport, it may not be a result of the procedure itself.

0 Comments

Obesity-associated microbiome composition can persist after weight loss, affecting the exchange of metabolites between a mouse and its resident bugs, researchers report.

0 Comments

image: Bacteria Show Signs of Starvation in Space

Bacteria Show Signs of Starvation in Space

By | November 18, 2016

E. coli cultured on the International Space Station show increased expression of genes related to starvation and acid-resistance responses, researchers report.

0 Comments

image: New Support for Experimental Alzheimer’s Drug

New Support for Experimental Alzheimer’s Drug

By | November 2, 2016

Merck’s verubecestat, which is currently being tested in two Phase 3 studies, is safe, according to newly published Phase 1 data.

2 Comments

image: Antarctic Bacteria Latch Onto Ice with Molecular Fishing Rod

Antarctic Bacteria Latch Onto Ice with Molecular Fishing Rod

By | November 1, 2016

Researchers describe the first known bacterial adhesion molecule that binds to frozen water. 

0 Comments

Popular Now

  1. Running on Empty
    Features Running on Empty

    Regularly taking breaks from eating—for hours or days—can trigger changes both expected, such as in metabolic dynamics and inflammation, and surprising, as in immune system function and cancer progression.

  2. Authors Peeved by APA’s Article Takedown Pilot
  3. Athletes’ Microbiomes Differ from Nonathletes
  4. Was a Drop in CRISPR Firms’ Stock Warranted?
AAAS